Publicaciones en colaboración con investigadores/as de Centro de Investigaciones Biológicas (140)

2024

  1. Evolution of human H3N2 influenza virus receptor specificity has substantially expanded the receptor-binding domain site

    Cell Host and Microbe, Vol. 32, Núm. 2, pp. 261-275.e4

2023

  1. Functional Characterization of a Familial ALS-Associated Missense TBK1 (p-Arg573Gly) Mutation in Patient-Derived Lymphoblasts

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

  2. Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers

    Current Oncology, Vol. 30, Núm. 3, pp. 2569-2581

  3. Neutrophil β1 adrenoceptor blockade blunts stroke-associated neuroinflammation

    British Journal of Pharmacology, Vol. 180, Núm. 4, pp. 459-478

  4. N′-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile

    Journal of Medicinal Chemistry, Vol. 66, Núm. 8, pp. 5465-5483

  5. Revealing the Specificity of Human H1 Influenza A Viruses to Complex N-Glycans

    JACS Au, Vol. 3, Núm. 3, pp. 868-878

2022

  1. Conformational and Structural Characterization of Carbohydrates and their Interactions Studied by NMR

    Current medicinal chemistry, Vol. 29, Núm. 7, pp. 1147-1172

  2. Discovery of Mitophagy Inhibitors with Therapeutic Potential in Different Familial Amyotrophic Lateral Sclerosis Mutations

    International Journal of Molecular Sciences, Vol. 23, Núm. 20

  3. Glycosylation of Epigallocatechin Gallate by Engineered Glycoside Hydrolases from Talaromyces amestolkiae: Potential Antiproliferative and Neuroprotective Effect of These Molecules

    Antioxidants, Vol. 11, Núm. 7

  4. Insulin receptor activation by proinsulin preserves synapses and vision in retinitis pigmentosa

    Cell Death and Disease, Vol. 13, Núm. 4

  5. New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

    Biomolecules, Vol. 12, Núm. 9

  6. TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy

    Journal of Medicinal Chemistry, Vol. 65, Núm. 2, pp. 1585-1607

  7. The Search for Antibacterial Inhibitors Targeting Cell Division Protein FtsZ at Its Nucleotide and Allosteric Binding Sites

    Biomedicines, Vol. 10, Núm. 8

  8. Transcriptomic Mapping of Non-Small Cell Lung Cancer K-RAS p.G12C Mutated Tumors: Identification of Surfaceome Targets and Immunologic Correlates

    Frontiers in Immunology, Vol. 12

2021

  1. Cdse quantum dots in human models derived from als patients: Characterization, nuclear penetration studies and multiplexing

    Nanomaterials, Vol. 11, Núm. 3, pp. 1-15

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Molecular alterations in sporadic and sod1-als immortalized lymphocytes: Towards a personalized therapy

    International Journal of Molecular Sciences, Vol. 22, Núm. 6, pp. 1-17

  4. Recent advances in the application of NMR methodologies to analyze the conformation, dynamics, and interactions of saccharides

    Carbohydrate Chemistry, Vol. 44, pp. 170-194

  5. Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis

    European Journal of Medicinal Chemistry, Vol. 210

  6. Targeting the FtsZ Allosteric Binding Site with a Novel Fluorescence Polarization Screen, Cytological and Structural Approaches for Antibacterial Discovery

    Journal of Medicinal Chemistry, Vol. 64, Núm. 9, pp. 5730-5745